Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · IEX Real-Time Price · USD
0.970
+0.045 (4.90%)
At close: Jul 19, 2024, 4:00 PM
0.930
-0.040 (-4.15%)
Pre-market: Jul 22, 2024, 9:02 AM EDT
Xilio Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +621.65% | May 30, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +621.65% | May 11, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $10 | Buy | Maintains | $20 → $10 | +930.93% | Jan 27, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +621.65% | Dec 21, 2022 |
| Raymond James | Raymond James | Buy Maintains $31 → $13 | Buy | Maintains | $31 → $13 | +1,240.21% | Nov 10, 2022 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $32 → $20 | Buy | Maintains | $32 → $20 | +1,961.86% | Aug 10, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +3,611.34% | Jan 10, 2022 |
| Raymond James | Raymond James | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 16, 2021 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 16, 2021 |
| Morgan Stanley | Morgan Stanley | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 16, 2021 |